Dossier
BPC-157, TB-500 10mg (Blend)
BPC-157 and TB-500 is a research peptide mixture consisting of two cytoprotective peptides, and whose influence on angiogenic and cytoskeletal signals is being studied.
Category page
Trending
All 13 research compounds in the trending category, with links to detailed product dossiers and molecule data.
Products
Trending compounds
All 13 research compounds in this category with links to product dossiers and data.
Dossier
BPC-157, TB-500 20mg (Blend)
The combination of BPC-157 and TB-500 combines two well-characterized research peptides that have been studied with respect to their roles in cellular repair, angiogenesis, and tissue remodeling.
Dossier
BPC-157, TB-500, GHK-Cu 30mg (Glow Blend)
BPC-157 5mg, TB-500 (Thymosin Beta-4) 5mg, GHK-Cu 20mg (30mg Total Glow Blend) Click here BPC-157, TB-500, GHK-Cu (Glow Blend) 60mg Mechanisms and Synergy BPC-157: A stable gastric pentadecapeptide that has been shown to accelerate angiogenesis, fibroblast migration, and epithelial repair by modulating the VEGFR2- and FAK-Paxillin pathways and nitric oxide signaling.
Dossier
BPC-157, TB-500, GHK-Cu 60mg (Glow Blend)
BPC-157 10mg, TB-500 (Thymosin Beta-4) 10mg, GHK-Cu 40mg (60mg Total Glow Blend) Click here BPC-157, TB-500, GHK-Cu (Glow Blend) 30mg Mechanisms and Synergy BPC-157: A stable gastric pentadecapeptide that has been shown to accelerate angiogenesis, fibroblast migration, and epithelial repair by modulating the VEGFR2- and FAK-Paxillin pathways and nitric oxide signaling.
Dossier
Gut Inflammation (60 Capsules) (Stable BPC-157 Arginate, KPV, Larazotide)
Gut inflammation is a research formulation that contains stable BPC-157, KPV, Palmitoylethanolamide (PEA), and tributyrin, and has been developed for studies on intestinal barrier function and modulation of inflammation.
Dossier
MOTS-c 10mg
MOTS-c is a research peptide derived from mitochondria, consisting of 16 amino acids (Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg).
Dossier
MOTS-c 5mg
MOTS-c is a mitochondrially derived research peptide that consists of 16 amino acids (Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg).
Dossier
NAD+ 100mg
NAD⁺ (Nicotinamide adenine dinucleotide) is an endogenous pyridine nucleotide that is widely used as a reference compound in experimental research focusing on cellular redox reactions and the regulation of metabolic signaling pathways.
Dossier
NAD+ 750mg
NAD⁺ (Nicotinamide Adenine Dinucleotide) is an essential redox coenzyme involved in cellular energy metabolism and mitochondrial homeostasis.
Dossier
NMN 500mg (60 Capsules)
NMN is a research compound that serves as a direct precursor of nicotinamide adenine dinucleotide (NAD⁺), a central cofactor in cellular redox metabolism.
Dossier
SLU-PP-332 (1000mcg x 30 Capsules = 30,000mcg)
SLU-PP-332 is an experimental compound designed to mimic the metabolic effects of training by activating estrogen-related receptors (ERRs), in particular ERRα, ERRβ and ERRγ.
Dossier
SLU-PP-332 (250mcg x 60 Capsules = 15,000mcg)
SLU-PP-332 is a small-molecule research compound that has been identified as a selective agonist of the peroxisome proliferator-activated receptor delta (PPARδ).
Dossier
Tesofensine 500mcg (30 Capsules)
Tesofensine is a synthetic small-molecule research compound that is classified as a triple monoamine reuptake inhibitor of serotonin, norepinephrine, and dopamine.
Explore
Related categories
Browse other research compound categories.